Monoamine oxidase A inhibitors

MAOI_A

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N06AG

6596

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

3653

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

3653

diagram downward connector

Include endpoints None

3653

diagram downward connector
MAOI_A

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 3653 2203 1450
Unadjusted prevalence (%) 1.03 1.11 0.92
Mean age at first event (years) 43.94 42.98 45.41

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.24 [0.91, 1.68] 1.8e-1 319
15 years 0.01 0.84 [0.63, 1.12] 2.3e-1 114
5 years 0.00 1.06 [0.73, 1.54] 7.6e-1 34
1 year 0.00 2.25 [1.27, 3.99] 5.4e-3 13

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: MAOI_A – Monoamine oxidase A inhibitors
GWS hits:

Survival analyses between endpoints

Plot

before Monoamine oxidase A inhibitors
after Monoamine oxidase A inhibitors

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Monoamine oxidase A inhibitors